These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7549996)

  • 41. Genetic switch underlies C. albicans quick change act.
    Vance E
    PLoS Biol; 2011 Jul; 9(7):e1001108. PubMed ID: 21811400
    [No Abstract]   [Full Text] [Related]  

  • 42. A novel role of the vacuolar calcium channel Yvc1 in stress response, morphogenesis and pathogenicity of Candida albicans.
    Yu Q; Wang F; Zhao Q; Chen J; Zhang B; Ding X; Wang H; Yang B; Lu G; Zhang B; Li M
    Int J Med Microbiol; 2014 May; 304(3-4):339-50. PubMed ID: 24368068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hgc1, a novel hypha-specific G1 cyclin-related protein regulates Candida albicans hyphal morphogenesis.
    Zheng X; Wang Y; Wang Y
    EMBO J; 2004 Apr; 23(8):1845-56. PubMed ID: 15071502
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathogenicity of Candida albicans: quest for a molecular switch.
    Datta A
    Braz J Med Biol Res; 1994 Dec; 27(12):2721-32. PubMed ID: 7549996
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current trends in Candida albicans research.
    Datta A; Ganesan K; Natarajan K
    Adv Microb Physiol; 1989; 30():53-88. PubMed ID: 2700541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Candida albicans: genetics, dimorphism and pathogenicity.
    Molero G; Díez-Orejas R; Navarro-García F; Monteoliva L; Pla J; Gil C; Sánchez-Pérez M; Nombela C
    Int Microbiol; 1998 Jun; 1(2):95-106. PubMed ID: 10943347
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Candida morphogenesis and host-pathogen interactions.
    Whiteway M; Oberholzer U
    Curr Opin Microbiol; 2004 Aug; 7(4):350-7. PubMed ID: 15358253
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Candida albicans, the opportunist. A cellular and molecular perspective.
    Dupont PF
    J Am Podiatr Med Assoc; 1995 Feb; 85(2):104-15. PubMed ID: 7877106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Candida albicans dimorphism as a therapeutic target.
    Jacobsen ID; Wilson D; Wächtler B; Brunke S; Naglik JR; Hube B
    Expert Rev Anti Infect Ther; 2012 Jan; 10(1):85-93. PubMed ID: 22149617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Ras/cAMP/PKA signaling pathway and virulence in Candida albicans.
    Hogan DA; Sundstrom P
    Future Microbiol; 2009 Dec; 4(10):1263-70. PubMed ID: 19995187
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.